| Breakdown | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 330.65M | 279.33M | 272.00M | 395.18M | 485.80M |
| Gross Profit | 59.36M | 57.32M | 53.49M | 87.03M | 90.58M |
| EBITDA | 69.87M | 50.00M | 51.33M | 98.53M | 102.06M |
| Net Income | 28.16M | 7.09M | 7.08M | 45.06M | 52.58M |
Balance Sheet | |||||
| Total Assets | 490.86M | 491.70M | 499.20M | 530.38M | 510.40M |
| Cash, Cash Equivalents and Short-Term Investments | 118.52M | 73.77M | 47.02M | 87.24M | 109.21M |
| Total Debt | 2.43M | 5.76M | 11.46M | 32.92M | 38.15M |
| Total Liabilities | 48.92M | 47.97M | 57.56M | 85.82M | 80.90M |
| Stockholders Equity | 441.94M | 443.73M | 441.64M | 444.56M | 429.50M |
Cash Flow | |||||
| Free Cash Flow | 75.58M | 41.34M | -4.09M | 36.26M | 112.74M |
| Operating Cash Flow | 78.35M | 46.54M | -3.57M | 43.10M | 116.50M |
| Investing Cash Flow | -238.00K | -3.89M | 1.77M | -28.60M | -4.25M |
| Financing Cash Flow | -33.54M | -15.22M | -37.62M | -35.51M | -72.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$13.87B | 3.26 | 11.37% | 4.26% | 2.60% | 49.21% | |
77 Outperform | HK$300.00M | 7.39 | 6.36% | 12.96% | 18.37% | 297.18% | |
76 Outperform | HK$15.62B | 8.06 | 10.40% | 4.49% | -9.90% | -20.25% | |
68 Neutral | HK$47.07B | 4.40 | 11.02% | 3.41% | 15.52% | -23.76% | |
67 Neutral | HK$2.01B | 8.68 | 9.37% | 0.53% | 19.37% | 75.13% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
44 Neutral | HK$1.11B | -5.14 | -10.88% | ― | -10.78% | -25.12% |